Stephen Baxter
Stock Analyst at Wells Fargo
(2.39)
# 2,460
Out of 5,180 analysts
257
Total ratings
43.03%
Success rate
-1.17%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CON Concentra Group Holdings Parent | Maintains: Overweight | $25 → $28 | $21.05 | +33.02% | 1 | Mar 5, 2026 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $235 → $212 | $182.10 | +16.42% | 18 | Mar 2, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $43 → $50 | $41.54 | +20.37% | 9 | Mar 2, 2026 | |
| AGL agilon health | Maintains: Overweight | $1 → $1.5 | $0.32 | +366.71% | 11 | Feb 27, 2026 | |
| MDLN Medline | Maintains: Equal-Weight | $42 → $47 | $42.62 | +10.28% | 2 | Feb 27, 2026 | |
| MOH Molina Healthcare | Downgrades: Equal-Weight | $208 → $141 | $131.47 | +7.25% | 23 | Feb 20, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $290 → $206 | $166.00 | +24.10% | 14 | Feb 18, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $43 → $44 | $31.80 | +38.36% | 26 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $405 → $429 | $309.93 | +38.42% | 6 | Feb 10, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $237 → $256 | $206.31 | +24.09% | 11 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $914 → $925 | $860.19 | +7.53% | 10 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $370 | $261.79 | +41.33% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $424 → $391 | $284.79 | +37.29% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $452 → $481 | $467.83 | +2.82% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $38 | $30.14 | +26.08% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $252 → $229 | $188.00 | +21.81% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3 → $2 | $2.87 | -30.31% | 12 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $10.85 | +1.38% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $70.14 | +45.42% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $258.08 | +16.24% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $5.14 | +191.83% | 3 | Apr 29, 2024 |
Concentra Group Holdings Parent
Mar 5, 2026
Maintains: Overweight
Price Target: $25 → $28
Current: $21.05
Upside: +33.02%
Universal Health Services
Mar 2, 2026
Maintains: Equal-Weight
Price Target: $235 → $212
Current: $182.10
Upside: +16.42%
BrightSpring Health Services
Mar 2, 2026
Maintains: Overweight
Price Target: $43 → $50
Current: $41.54
Upside: +20.37%
agilon health
Feb 27, 2026
Maintains: Overweight
Price Target: $1 → $1.5
Current: $0.32
Upside: +366.71%
Medline
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $42 → $47
Current: $42.62
Upside: +10.28%
Molina Healthcare
Feb 20, 2026
Downgrades: Equal-Weight
Price Target: $208 → $141
Current: $131.47
Upside: +7.25%
Humana
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $290 → $206
Current: $166.00
Upside: +24.10%
Centene
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $43 → $44
Current: $31.80
Upside: +38.36%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $405 → $429
Current: $309.93
Upside: +38.42%
Cardinal Health
Feb 10, 2026
Maintains: Overweight
Price Target: $237 → $256
Current: $206.31
Upside: +24.09%
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $914 → $925
Current: $860.19
Upside: +7.53%
Jan 30, 2026
Maintains: Overweight
Price Target: $400 → $370
Current: $261.79
Upside: +41.33%
Jan 30, 2026
Maintains: Overweight
Price Target: $424 → $391
Current: $284.79
Upside: +37.29%
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $452 → $481
Current: $467.83
Upside: +2.82%
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $30.14
Upside: +26.08%
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $188.00
Upside: +21.81%
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $2.87
Upside: -30.31%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $10.85
Upside: +1.38%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $70.14
Upside: +45.42%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $258.08
Upside: +16.24%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $5.14
Upside: +191.83%